Navigation Links
SYNCHRON CX®4 Super

ProductsSYNCHRON CX®4 Super
Company Beckman Coulter, Inc.
Item SYNCHRON CX®4 Super
Features 
  • 24 onboard chemistries
  • 225 tests per hour throughput
  • Up to 63 sample capacity with continuous loading capability
  • Onboard reagent stability of up to 60 days (up to 90 days for electrolyte reagents)
  • Easy to use.
  • Continuous random access for samples, controls calibrators and results
  • No-wait autoloader
  • 96 bar-coded, liquid analytes, most ready-to-use
  • Bar-coded calibrators and controls
  • Easy to maintain.
  • Factory reconditioning means improved reliability
  • Permanent glass cuvettes eliminate replacement
  • Long-lasting (more than 5 years) pulsed Xenon lamp reduces calibration and maintenance
  • Easy to acquire.
  • Affordable systems from an industry leader
  • Combine with Access® for workstation consolidation
Description The SYNCHRON CX4-S system consolidates DATs, TDMs and other esoteric tests in one workstation, targeted to the mid-size lab that processes 50-200 samples per day. Like all SYNCHRON CX super systems, the CX4-S is easy to use, easy to maintain and easy to acquire.
Info Beckman Coulter, Inc.
Customer Service: (800) 742-2345

Related medicine products :

1. SYNCHRON CX® 4 Delta
2. SYNCHRON CX 3 Delta
3. SYNCHRON CX 4 PRO
4. SYNCHRON LX® 2000 PRO
5. SYNCHRON CX5 PRO
6. SYNCHRON® CX500 PRO System
7. SYNCHRON LX®20 PRO
8. SYNCHRON CX® 1000 PRO Clinical System
9. SYNCHRON CX®9 PRO Clinical System
10. SYNCHRON LX4201
11. SYNCHRON LX® 20
This cannula features a guidewire stylet, manually inflatable smooth cuff, wirewound silicone body, and pressure monitoring line...
...
The Select 3D Arterial cannulae from Medtronic features a tip configuration which diffuses the flow through multiple outlets. This unique tip design provides reduced velocity with one central and thr...
The Medtronic EOPA CAP® arterial cannula provides a simple solution to obtaining accurate arterial pressure readings....
Medicine Products:
(Date:8/17/2017)... ... August 17, 2017 , ... Finalists in ... competition, were announced today. The awards recognize the world’s best employers and the ... create and drive great places to work. , A diverse group of organizations ...
(Date:8/17/2017)... Seattle, WA and Lighthouse Point, FL (PRWEB) , ... ... ... Seattle-based healthcare technology firm and Cancer Center Business Development Group, a Florida-based oncology ... that examined patient care data to quantify the dollar amount of attributable savings ...
(Date:8/16/2017)... ... 16, 2017 , ... The next Patient Care Academy at Kalamazoo Valley Community ... successfully complete the seven-week long Patient Care Academy are eligible to take the State ... for a CNA in Kalamazoo is $24,428.* , As a CNA, one is equipped ...
(Date:8/16/2017)... ... 2017 , ... An August 3rd article on Reuters covers a new University of ... JAMA (the Journal of the American Medical Association). The study found that a lower percentage ... 30, when compared to patients with lower BMIs. At present, weight loss patients must have ...
(Date:8/16/2017)... ... August 16, 2017 , ... Ten outstanding teachers in the Greater Houston ... and will win a visit by a Houston Texans player, two tickets to a ... five years old can visit texanschecking.com/stars to nominate their favorite teacher with an essay ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... 3, 2017  Agragen, LLC, a ... the biopharmaceutical, nutraceutical, and aquacultural feed sectors, announces ... lead drug candidates, AGR131.  This drug is designed ... the blood of patients suffering from inflammatory conditions ... disease. Biological ...
(Date:8/2/2017)... and BENTON, Ky. , Aug. 2, 2017   Marshall County ... its environmental services (ES) team to proactively reduce the risk of hospital-acquired infections (HAIs). The ... disinfection robot that uses UVC light energy to kill deadly pathogens such as C. ... Tru-D SmartUVC ... Tru-D in action in ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: